CTSO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cytosorbents Corp (CTSO) does not currently present a strong buy opportunity for a beginner investor with a long-term focus. The technical indicators are bearish, and there are no strong trading signals or significant positive momentum in the stock price. While the company has shown improvements in revenue and gross margin, its net income remains negative, and the stock is trading below key support levels. Given the lack of strong catalysts or favorable sentiment, holding off on investing in CTSO is recommended at this time.
The technical indicators for CTSO are bearish. The MACD is negatively expanding, the RSI is neutral but leaning towards oversold territory, and the moving averages indicate a downward trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 0.627, with resistance at 0.72. Overall, the technical outlook suggests weakness in the stock's price trend.
The company recently launched HotSwap™, a product aimed at improving critical care treatment efficiency. Additionally, CytoSorbents renewed its exclusive distribution agreement with Aferetica Srl, which could strengthen its market presence in Italy. Clinical data presented at ISICEM 2026 highlighted the effectiveness of CytoSorb in improving patient outcomes, reinforcing the company's leadership in blood purification.
The stock has shown a consistent downward trend, with no significant insider or hedge fund activity to suggest confidence in the stock. The lack of recent congress trading data and bearish technical indicators further weigh against the stock's short-term potential.
In Q3 2025, the company showed a 10.12% YoY increase in revenue to $9.485 million and a 15.18% YoY improvement in gross margin to 70.28%. However, net income remains negative at -$3.17 million, albeit improving by 14.52% YoY. EPS remained unchanged at -0.05. While there are signs of operational improvement, the company is not yet profitable.
No recent analyst rating or price target changes are available for CTSO.
